Clinical trials
Alopecia clinical trials
Below are recruiting alopecia clinical trials, each written for real people, not researchers. We’re tracking 82 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07381556RecruitingPhase 4
Comparing cyclosporine and methotrexate for kids with alopecia areata
This study compares two medicines, cyclosporine and methotrexate, to see which works better for children with alopecia areata (a condition causing hair loss). It aims to help doctors choose the best treatment for each child.
RotterdamAges 2–17 - NCT06283316Recruiting
A registry for alopecia areata treatments
This trial is a registry that collects information from people with alopecia areata who are starting or using body-wide treatments. It helps doctors learn more about how these treatments work in real life.
RotterdamAges 16 years+ - NCT07733063Recruiting
Blood markers for ferroptosis in Alopecia Areata
This study looks at certain blood markers (GPX4 and MDA) related to a process called ferroptosis in people with Alopecia Areata. The goal is to better understand this condition and possibly find new treatment targets.
Istanbul, Cerrahpasa MahallesiAges 18–65 - NCT05460611Recruiting
1470nm laser treatment for certain types of hair loss
This study tests whether a specific 1470nm laser can improve hair loss in people with certain scalp conditions. It looks for people whose hair loss is stable for several months and who can keep their usual hair treatments unchanged during the study.
Elmsford, New YorkAges 18–99 - NCT06747611RecruitingPhase 2
Gut bacteria transplant for alopecia areata
This study tests whether transplanting healthy gut bacteria can help people with moderate to severe alopecia areata regrow hair. You will take antibiotics to prepare your gut, then receive the transplant through a colonoscopy or capsules.
Minneapolis, MinnesotaAges 18–75 - NCT07499713Enrolling by invitation
Blood proteins and nail blood vessels in alopecia areata
This study looks at whether certain proteins in your blood (VEGF-A and VCAM-1) are linked to changes in the tiny blood vessels at the base of your fingernails in people with alopecia areata. It may help doctors understand more about the condition and how it affects the body.
IstanbulAges 18–60 - NCT07508488RecruitingPhase 2
Deucravacitinib for scarring hair loss (Phase 2)
This study tests an oral medication called deucravacitinib for people with scarring hair loss (frontal fibrosing alopecia or central centrifugal cicatricial alopecia). It aims to see if the drug can reduce inflammation and stop or slow hair loss.
New York, New YorkAges 18 years+ - NCT05723198RecruitingPhase 3
Baricitinib for severe childhood hair loss from alopecia areata
This trial tests whether baricitinib can improve severe alopecia areata (patchy, autoimmune hair loss) in children and teens. It’s meant for people who have had long-lasting, severe hair loss and have tried other treatments without enough benefit.
Birmingham, AlabamaAges 6–17 - NCT07107841Recruiting
Hair follicle treatment for pattern baldness
This study tests an experimental treatment using a substance made from your own hair follicles to see if it can help regrow hair in people with pattern baldness. It involves getting several small injections into your scalp over time.
West Hollywood, CaliforniaAges 18–65 - NCT07563036Recruiting
JAK2 Protein Changes in Male Pattern Baldness With Minoxidil
This study examines how a protein called JAK2 changes in the scalp when men with male pattern baldness use minoxidil (Rogaine), a common hair-loss treatment. Understanding this might help explain why minoxidil works and improve future treatments.
Cairo, Cairo GovernorateAges 18–50 - NCT06764329Enrolling by invitationPhase 1/Phase 2
Stem cell therapy for male hair loss
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
RawalpindiAges 20–59 - NCT06292533Enrolling by invitation
Ultrapulse for hair loss in Malaysian men and women
This study tests if Ultrapulse treatment helps regrow hair in people with male or female pattern baldness. It may be an option if you haven't used hair loss medications recently or had certain scalp procedures.
Bandar Puchong Jaya, SelangorAges 18 years+ - NCT06562270Recruiting
Teens with severe alopecia areata: treatment safety study
This study tracks the safety and effectiveness of alopecia areata treatments in teenagers aged 12-17. It helps doctors understand which treatments work best and are safest for young people with severe hair loss.
Waltham, MassachusettsAges 12–17 - NCT06873945RecruitingPhase 3
Study of two doses of ritlecitinib for alopecia areata
This study tests two different doses of a pill called ritlecitinib to see if it can help regrow hair in people with significant hair loss from alopecia areata. It is for people aged 12 and older who have lost at least half of their scalp hair.
Birmingham, AlabamaAges 12 years+ - NCT05417308RecruitingEarly Phase 1
Minoxidil for hair loss from breast cancer hormone therapy
This early-phase study tests whether using minoxidil as a lotion (topical) or by mouth (oral) can improve hair loss caused by breast cancer hormone (endocrine) therapy. It may help you keep or regrow hair while continuing your cancer treatment.
Columbus, OhioAges 18 years+ - NCT04764331Recruiting
Red light cap for scar-forming hair loss in women
This pilot study tests an “all LED” red light cap to treat central centrifugal cicatricial alopecia (CCCA), a type of scarring hair loss. If you’re a woman with confirmed CCCA at Stage II–III and stable treatment, the study may help see whether red light can improve your hair loss without changing your current plan.
Winston-Salem, North CarolinaAges 18–75 - NCT05177289Recruiting
Light therapy to prevent hair loss during chemotherapy
This study tests whether photobiomodulation (a specific light therapy) can prevent or reduce hair loss caused by chemotherapy. It may help you keep more hair or grow hair back sooner while you’re getting treatment.
Hasselt, LimburgAges 18 years+ - NCT07340671Recruiting
Laser treatment for facial bumps in frontal fibrosing alopecia
This study tests whether laser therapy can help treat small bumps (papules) that appear on the face in people with frontal fibrosing alopecia, a type of hair loss. If you have these bumps and are generally healthy, you may be able to join.
Miami, FloridaAges 18 years+ - NCT06012240RecruitingPhase 3
Testing Upadacitinib for Severe Alopecia Areata
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
Birmingham, AlabamaAges 12–63 - NCT05213936Recruiting
Scalp cooling to prevent hair loss during chemotherapy
This trial tests whether cooling the scalp during chemotherapy can help reduce chemotherapy-related hair loss. It focuses on people with curly or kinky hair who are having certain cancer treatments, and it checks safety and how much hair loss happens.
The Bronx, New YorkAges 18 years+ - NCT04207931RecruitingPhase 4
Study of treatments for a specific scar-ring hair loss
This study looks at treatment results for central centrifugal cicatricial alopecia (CCCA), a type of hair loss that causes scarring and permanent hair loss. It will follow African-American women to see how well treatments work for different levels of severity.
Winston-Salem, North CarolinaAges 18–60 - NCT04594018RecruitingPhase 3
Test a hair lotion for male pattern hair loss
This Phase 3 study tests whether a specific hair lotion works and is safe for men with male pattern hair loss. It also checks that results are consistent while you keep similar hair care and avoid certain other hair-loss treatments.
Osasco, São PauloAges 18–60 - NCT04764357Recruiting
Scalp cooling to help prevent chemotherapy-related hair loss in kids
This study looks at whether “cold cap” scalp cooling can help prevent or reduce hair loss in children getting chemotherapy. It’s aimed at kids treated with certain chemotherapy medicines and who may be at risk for losing their hair.
Memphis, TennesseeAges 7 years+ - NCT05398809RecruitingPhase 2
Ruxolitinib for hair regrowth in APECED-related alopecia areata
This Phase 2 study tests ruxolitinib to see if it safely helps regrow hair in people whose alopecia areata is linked to APECED (a rare immune condition). You may qualify if you have significant scalp hair loss for at least 6 months and haven’t had regrowth with other treatments.
Bethesda, MarylandAges 12–75
Hear when a new Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Alopecia trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for alopecia?
- Yes. Clin2 currently lists 82 recruiting alopecia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alopecia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alopecia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.